FiscalNote Holdings, Inc. (NOTE): Nasdaq/NYSE listing notice — FiscalNote receives NYSE delisting notice for share price below $1.00

FiscalNote Holdings, Inc.

NYSE notified FiscalNote on April 10, 2025 that its 30-day average closing price fell below $1.00.
Company has six months to regain compliance; must have closing price ≥$1.00 on last trading day of any calendar month and 30-day average ≥$1.00.
FiscalNote must notify NYSE of its intent to cure within 10 business days; Board is reviewing alternatives.
NYSE notification does not affect business operations, SEC reporting, or trigger default under debt agreements.
Common stock (NOTE) continues trading on NYSE pending cure; warrants (NOTE.WS) also listed.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

FiscalNote Holdings, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

April 10, 2025, FiscalNote Holdings, Inc. (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) stating that it has concluded that the Company is not in compliance with Rule 802.01C of the NYSE’s continued listing requirements (the “NYSE Notification”), since as of April 9, 2025, the 30-trading day average closing price of the Company’s shares of Class A common stock, par value $0.0001 per share (the “Common Stock”) had fallen below $1.00 per share over a consecutive 30 trading-day period. Within 10 business days of receipt of the NYSE Notification, the Company must not

View on SEC.gov

Browse all listing & compliance notices →

FiscalNote Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-053292

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.